The Patient’s Voice is the pharmaceutical industry’s meeting place and expert community for key stakeholders in the development of new therapies for patients. We set each conference’s agenda to enable attendees to implement the perspectives of patients, pharma industry leaders, clinical research professionals, and investigators into their drug development process.
Both globally oriented and locally focused, the Patient’s Voice offers a central platform with patient panels, business workshops, and expert talks presenting cutting-edge strategies to infuse patient-centricity into the DNA of clinical research. From designing patient-friendly and feasible clinical trials to successfully recruit, retain, and engage patients, effectively reducing time to market as well as ensuring you meet current patient needs and improve their clinical trial experiences.
Connecting patients, sponsors and sites annually, the Patient’s Voice has quickly become the benchmark event for industry leaders to hear and learn directly from patients as well as colleagues, and for ideas to become actions.
Within the last 3 years, the Patient’s Voice conference has developed into one of the most interesting meeting points focusing on patient-centric R&D in the pharma sector.
This highly interactive 1.5-day event provides you with the opportunity to gain firsthand experience with both patients who have participated in clinical trials, as well as those who are still considering their options. These insights help all of us understand patient comprehension of clinical trials and teaches us how to design and implement patient-friendly protocols.
The patient panels, as well as the keynote speeches of industry leaders, will give you the possibility to enhance your trial design results and improve enrollment rates, help to avoid protocol amendments, leading to the completion of your clinical studies on time and on budget, reducing your time to market.
Invitees are R&D leaders who are working in the pharmaceutical industry only.
There is no cost for industry leaders focused on patient insights to attend this conference.